Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells

Developing cellular models of sporadic Alzheimer’s disease (sAD) is challenging due to the unknown initiator of disease onset and the slow disease progression that takes many years to develop in vivo. The use of human induced pluripotent stem cells (iPSCs) has revolutionised the opportunities to mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowland, Helen A., Hooper, Nigel M., Kellett, Katherine A. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Overview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267251/
https://www.ncbi.nlm.nih.gov/pubmed/30387070
http://dx.doi.org/10.1007/s11064-018-2663-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267251/
https://www.ncbi.nlm.nih.gov/pubmed/30387070
http://dx.doi.org/10.1007/s11064-018-2663-z

Ejemplares similares